bpc 157 peptide evidence human clinical trials safety Is BPC‑157 a Risk? Safety, Side Effects, and Concerns Explained bpc-157 human clinical trials evidence
Description
Ischemia & Cytoprotection In models of heart attack (ischemia-reperfusion), NAD+ administration reduced infarct size by up to 85%
Lebovitz HE
Supportive therapy in conditions requiring increased Vitamin C levels (e.g., chronic infections, wound healing)
A common polymorphism in HIBCH influences methylmalonic acid concentrations in blood independently of cobalamin Am J Hum Genet 2016;98:869-82
